BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23969949)

  • 1. Effect of temozolomide in patients with metastatic bronchial carcinoids.
    Crona J; Fanola I; Lindholm DP; Antonodimitrakis P; Öberg K; Eriksson B; Granberg D
    Neuroendocrinology; 2013; 98(2):151-5. PubMed ID: 23969949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.
    Ekeblad S; Sundin A; Janson ET; Welin S; Granberg D; Kindmark H; Dunder K; Kozlovacki G; Orlefors H; Sigurd M; Oberg K; Eriksson B; Skogseid B
    Clin Cancer Res; 2007 May; 13(10):2986-91. PubMed ID: 17505000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine and Temozolomide in Patients with Advanced Pulmonary Carcinoid Tumours.
    Papaxoinis G; Kordatou Z; McCallum L; Nasralla M; Lamarca A; Backen A; Nonaka D; Mansoor W
    Neuroendocrinology; 2020; 110(5):413-421. PubMed ID: 31437838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide: a safe and effective treatment for malignant digestive endocrine tumors.
    Maire F; Hammel P; Faivre S; Hentic O; Yapur L; Larroque B; Couvelard A; Zappa M; Raymond E; Lévy P; Ruszniewski P
    Neuroendocrinology; 2009; 90(1):67-72. PubMed ID: 19521065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchial carcinoid tumors: nodal status and long-term survival after resection.
    Cardillo G; Sera F; Di Martino M; Graziano P; Giunti R; Carbone L; Facciolo F; Martelli M
    Ann Thorac Surg; 2004 May; 77(5):1781-5. PubMed ID: 15111186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
    Hainsworth JD; Shih KC; Shepard GC; Tillinghast GW; Brinker BT; Spigel DR
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):240-6. PubMed ID: 22706484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
    Fine RL; Gulati AP; Krantz BA; Moss RA; Schreibman S; Tsushima DA; Mowatt KB; Dinnen RD; Mao Y; Stevens PD; Schrope B; Allendorf J; Lee JA; Sherman WH; Chabot JA
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):663-70. PubMed ID: 23370660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capecitabine and Temozolomide as a Promising Therapy for Advanced Thymic Atypical Carcinoid.
    Wang X; Li Y; Duan J; Chen Y; Yuan B; Qi Z; Tan H
    Oncologist; 2019 Jun; 24(6):798-802. PubMed ID: 30413666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Temozolomide as therapeutic option for patients with metastatic melanoma and poor prognosis].
    Frick S; Lischner S; Rosien F; Haacke TC; Schäfer F; Christophers E; Hauschild A
    Hautarzt; 2002 Oct; 53(10):659-65. PubMed ID: 12297947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
    Agarwala SS; Kirkwood JM; Gore M; Dreno B; Thatcher N; Czarnetski B; Atkins M; Buzaid A; Skarlos D; Rankin EM
    J Clin Oncol; 2004 Jun; 22(11):2101-7. PubMed ID: 15169796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy.
    Saif MW; Kaley K; Brennan M; Garcon MC; Rodriguez G; Rodriguez T
    JOP; 2013 Sep; 14(5):498-501. PubMed ID: 24018594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.
    Kulke MH; Stuart K; Enzinger PC; Ryan DP; Clark JW; Muzikansky A; Vincitore M; Michelini A; Fuchs CS
    J Clin Oncol; 2006 Jan; 24(3):401-6. PubMed ID: 16421420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
    Hadoux J; Favier J; Scoazec JY; Leboulleux S; Al Ghuzlan A; Caramella C; Déandreis D; Borget I; Loriot C; Chougnet C; Letouzé E; Young J; Amar L; Bertherat J; Libé R; Dumont F; Deschamps F; Schlumberger M; Gimenez-Roqueplo AP; Baudin E
    Int J Cancer; 2014 Dec; 135(11):2711-20. PubMed ID: 24752622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
    Chamberlain MC; Tsao-Wei DD
    Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms.
    Al-Toubah T; Morse B; Strosberg J
    Oncologist; 2020 Jan; 25(1):e48-e52. PubMed ID: 31455747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids.
    Sullivan I; Le Teuff G; Guigay J; Caramella C; Berdelou A; Leboulleux S; Déandréis D; Hadoux J; Ducreux M; Duvillard P; Adam J; Scoazec JY; Baudin E; Planchard D
    Eur J Cancer; 2017 Apr; 75():259-267. PubMed ID: 28242503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG).
    Trudeau ME; Crump M; Charpentier D; Yelle L; Bordeleau L; Matthews S; Eisenhauer E
    Ann Oncol; 2006 Jun; 17(6):952-6. PubMed ID: 16565212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of capecitabine and temozolomide combination in well-differentiated neuroendocrine tumors: Jordan experience.
    Abbasi S; Kashashna A; Albaba H
    Pancreas; 2014 Nov; 43(8):1303-5. PubMed ID: 25036906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review.
    Brizzi MP; La Salvia A; Tampellini M; Sonetto C; Volante M; Scagliotti GV
    BMC Cancer; 2018 Mar; 18(1):311. PubMed ID: 29558899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors.
    Chong CR; Wirth LJ; Nishino M; Chen AB; Sholl LM; Kulke MH; McNamee CJ; Jänne PA; Johnson BE
    Lung Cancer; 2014 Nov; 86(2):241-6. PubMed ID: 25218177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.